These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 29244961)
1. Time-dependent therapeutic roles of nitazoxanide on high-fat diet/streptozotocin-induced diabetes in rats: effects on hepatic peroxisome proliferator-activated receptor-gamma receptors. Elaidy SM; Hussain MA; El-Kherbetawy MK Can J Physiol Pharmacol; 2018 May; 96(5):485-497. PubMed ID: 29244961 [TBL] [Abstract][Full Text] [Related]
2. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats. Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ. Elkholy SE; Elaidy SM; El-Sherbeeny NA; Toraih EA; El-Gawly HW Life Sci; 2020 Jun; 250():117557. PubMed ID: 32184124 [TBL] [Abstract][Full Text] [Related]
4. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238 [TBL] [Abstract][Full Text] [Related]
5. Effects of allyl isothiocyanate on insulin resistance, oxidative stress status, and transcription factors in high-fat diet/streptozotocin-induced type 2 diabetes mellitus in rats. Sahin N; Orhan C; Erten F; Tuzcu M; Defo Deeh PB; Ozercan IH; Juturu V; Kazim S J Biochem Mol Toxicol; 2019 Jul; 33(7):e22328. PubMed ID: 30927557 [TBL] [Abstract][Full Text] [Related]
6. Potential role of peroxisome proliferator activated receptor gamma activation on serum visfatin and trace elements in high fat diet induced type 2 diabetes mellitus. Tabassum A; Zaidi SNF; Yasmeen K; Mahboob T Life Sci; 2018 Jul; 205():164-175. PubMed ID: 29772226 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of PPARγ by Aegle marmelos ameliorates insulin resistance and β-cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Sharma AK; Bharti S; Goyal S; Arora S; Nepal S; Kishore K; Joshi S; Kumari S; Arya DS Phytother Res; 2011 Oct; 25(10):1457-65. PubMed ID: 21351301 [TBL] [Abstract][Full Text] [Related]
8. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038 [TBL] [Abstract][Full Text] [Related]
9. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet. Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158 [TBL] [Abstract][Full Text] [Related]
10. Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Antony PJ; Gandhi GR; Stalin A; Balakrishna K; Toppo E; Sivasankaran K; Ignacimuthu S; Al-Dhabi NA Biomed Pharmacother; 2017 Apr; 88():1098-1113. PubMed ID: 28192884 [TBL] [Abstract][Full Text] [Related]
11. [Roles of MicroRNA-21 in the Pathogenesis of Insulin Resistance and Diabetic Mellitus-induced Non-alcoholic Fatty Liver Disease]. Zhao XY; Shao K Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):144-9. PubMed ID: 27181889 [TBL] [Abstract][Full Text] [Related]
12. Chebulagic acid attenuates HFD/streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR γ and GLUT 4 in type 2 diabetic rats. Vasu G; Sundaram R; Muthu K Toxicol Mech Methods; 2022 Mar; 32(3):159-170. PubMed ID: 34470562 [TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Sahin K; Tuzcu M; Orhan C; Sahin N; Kucuk O; Ozercan IH; Juturu V; Komorowski JR Br J Nutr; 2013 Jul; 110(2):197-205. PubMed ID: 23211098 [TBL] [Abstract][Full Text] [Related]
14. Role of peroxisome proliferator-activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus. Tabassum A; Mahboob T Hum Exp Toxicol; 2018 Nov; 37(11):1187-1198. PubMed ID: 29441829 [TBL] [Abstract][Full Text] [Related]
15. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice. Rhee KJ; Lee CG; Kim SW; Gim DH; Kim HC; Jung BD Int J Med Sci; 2015; 12(12):987-94. PubMed ID: 26664261 [TBL] [Abstract][Full Text] [Related]
16. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs. Shen X; Li H; Li W; Wu X; Ding X Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128 [TBL] [Abstract][Full Text] [Related]
17. Effect of CAPE-pNO Li S; Huang Q; Zhang L; Qiao X; Zhang Y; Tang F; Li Z Eur J Pharmacol; 2019 Jun; 853():1-10. PubMed ID: 30885574 [TBL] [Abstract][Full Text] [Related]
18. Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content. Balasubramanian R; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R Diabet Med; 2010 Feb; 27(2):150-6. PubMed ID: 20546257 [TBL] [Abstract][Full Text] [Related]
19. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats. Mokashi P; Bhatt LK; Khanna A; Pandita N Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588 [TBL] [Abstract][Full Text] [Related]
20. A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro. Ren T; Yang WS; Lin Y; Liu JF; Li Y; Yang LC; Zeng KY; Peng L; Liu YJ; Ye ZH; Luo XM; Ke YJ; Diao Y; Jin X Eur J Pharmacol; 2018 May; 826():1-8. PubMed ID: 29476879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]